A 59-year-old with NSTEMI receives dual antiplatelet therapy and is stable. He asks about duration after DES. No high bleeding risk. Recommendation?...

Question

A 59-year-old with NSTEMI receives dual antiplatelet therapy and is stable. He asks about duration after DES. No high bleeding risk. Recommendation?

Accepted Answer

12 months

Answer

1 month

Answer

3 months

Answer

6 months

Answer

Indefinitely for both agents

us-abim MCQ (SBA): DAPT Duration after ACS